Universe · entity
Avoro Capital Advisors LLC
Institutional manager (13F) · CIK 1633313
13F holdings · as of 2026-03-31 · top 30 · reported portfolio $10.2B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP | $1.6B | 2,630,000 |
| 2 | ASCENDIS PHARMA | $1.2B | 5,062,500 |
| 3 | MADRIGAL PHARMACEUTICALS INC | $952M | 1,818,181 |
| 4 | KRYSTAL BIOTECH INC | $746M | 2,888,888 |
| 5 | ARGENX SE | $730M | 1,000,000 |
| 6 | ARROWHEAD PHARMACEUTICALS INC | $671M | 10,699,999 |
| 7 | KYMERA THERAPEUTICS INC | $623M | 7,474,747 |
| 8 | APELLIS PHARMACEUTICALS INC | $492M | 12,222,222 |
| 9 | CENTESSA PHARMACEUTICALS PLC | $454M | 11,430,455 |
| 10 | CELCUITY INC | $385M | 3,375,000 |
| 11 | XENON PHARMACEUTICALS INC | $336M | 5,777,777 |
| 12 | STRUCTURE THERAPEUTICS INC | $316M | 6,555,555 |
| 13 | TERNS PHARMACEUTICALS INC | $300M | 5,695,000 |
| 14 | VERA THERAPEUTICS INC | $237M | 5,888,888 |
| 15 | REVOLUTION MEDICINES INC | $228M | 2,344,444 |
| 16 | CYTOKINETICS INC | $220M | 3,333,333 |
| 17 | OCULAR THERAPEUTIX INC | $104M | 12,315,000 |
| 18 | DAMORA THERAPEUTICS INC | $98M | 3,783,000 |
| 19 | UNIQURE NV | $97M | 5,959,595 |
| 20 | TAYSHA GENE THERAPIES INC | $97M | 21,700,000 |
| 21 | DEFINIUM THERAPEUTICS INC | $95M | 5,000,000 |
| 22 | SOLENO THERAPEUTICS INC | $77M | 2,300,000 |
| 23 | ALKERMES PLC | $42M | 1,200,000 |
| 24 | SEPTERNA INC | $32M | 1,337,500 |
| 25 | VIRIDIAN THERAPEUTICS INC | $29M | 1,500,000 |
| 26 | GH RESEARCH PLC | $25M | 1,800,000 |
| 27 | AVALO THERAPEUTICS | $21M | 1,410,000 |
| 28 | LEXEO THERAPEUTICS INC | $11M | 1,875,000 |
| 29 | WHITEHAWK THERAPEUTICS INC | $10M | 2,849,402 |
| 30 | MANNKIND CORP | $5M | 2,200,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.